Skip to content

Search the library by company, product or topic.

↵open↑↓navigateescclose

Castor

Clinical trial data platform (electronic data capture, outcome assessment and eConsent) for device, biopharma, diagnostics and academic research teams.

castoredc.com

At a glance

Founded
2012
Business model
B2B
Products profiled
1
Sources cited
5
In the library since
24 September 2026

What it does

Castor sells software for clinical research: electronic data capture (Castor EDC/CDMS), with eCOA and ePRO and eConsent as add-ons, for medical device, biopharma, diagnostics and academic research teams, and an AI-driven data extraction product it calls Castor Catalyst.

What the company says

The company’s own statements, attributed to it and not presented as established fact.

The company says it started in 2012 as a project by Dr. Derk Arts, reports more than 8 million patients and use in more than 170 countries (its about page gives two study counts, more than 17,000 and more than 19,000), and says that in one sponsor study reviewers accepted 99.16 percent of the values Catalyst extracted. In March 2026 it said it had joined the Critical Path Institute's eCOA Consortium and passed 300 industry studies.

Notes on this record

The registered name, headquarters, markets, funding stage and employee range are not recorded: the company began in Amsterdam, but no page read names a current headquarters.

Products

More of Recent HealthTech